Olawade, David B., Teke, Jennifer, Adeleye, Khadijat K., Egbon, Eghosasere, Weerasinghe, Kusal, Ovsepian, Saak V. and Boussios, Stergios (2024) AI-guided cancer therapy for patients with coexisting migraines. Cancers, 16 (21):3690. ISSN 2072-6694 (Online) (doi:10.3390/cancers16213690)

Preview

PDF (Open Access Article) 48654 OVSEPIAN_AI-Guided_Cancer_Therapy_For_Patients_With_Coexisting_Migraines_(OA)_2024.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Background: Cancer remains a leading cause of death worldwide. Progress in its effective treatment has been hampered by challenges in personalized therapy, particularly in patients with comorbid conditions. The integration of artificial intelligence (AI) into patient profiling offers a promising approach to enhancing individualized anticancer therapy. Objective: This narrative review explores the role of AI in refining anticancer therapy through personalized profiling, with a specific focus on cancer patients with comorbid migraine. Methods: A comprehensive literature search was conducted across multiple databases, including PubMed, Scopus, and Google Scholar. Studies were selected based on their relevance to AI applications in oncology and migraine management, with a focus on personalized medicine and predictive modeling. Key themes were synthesized to provide an overview of recent developments, challenges, and emerging directions. Results: AI technologies, such as machine learning (ML), deep learning (DL), and natural language processing (NLP), have become instrumental in the discovery of genetic and molecular biomarkers of cancer and migraine. These technologies also enable predictive analytics for assessing the impact of migraine on cancer therapy in comorbid cases, predicting outcomes and provide clinical decision support systems (CDSS) for real-time treatment adjustments. Conclusions: AI holds significant potential to improve the precision and effectiveness of the management and therapy of cancer patients with comorbid migraine. Nevertheless, challenges remain over data integration, clinical validation, and ethical consideration, which must be addressed to appreciate the full potential for the approach outlined herein.

Item Type:	Article
Additional Information:	This article belongs to the Section Methods and Technologies Development.
Uncontrolled Keywords:	artificial intelligence, machine learning, anticancer therapy, patient profiling, migraine, personalized medicine, predictive modeling
Subjects:	Q Science > QA Mathematics > QA75 Electronic computers. Computer science R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	18 Nov 2024 16:39
URI:	http://gala.gre.ac.uk/id/eprint/48654

Actions (login required)

View Item

Downloads